H.R. 5668 · 116th Congress
Making Objective Drug Evidence Revisions for New Labeling Act of 2020
- Stage
- Passed a chamber
- Sponsor
- Doris Matsui
- Introduced
- 2020-01-24
- Latest action
- 2020-11-18 · Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Votes
No linked votes are available for this bill.